Pathstone Holdings, LLC Cytokinetics Inc Transaction History
Pathstone Holdings, LLC
- $22.2 Billion
- Q4 2024
A detailed history of Pathstone Holdings, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 26,294 shares of CYTK stock, worth $1.21 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,294
Previous 34,560
23.92%
Holding current value
$1.21 Million
Previous $1.82 Million
32.24%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$675 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$548 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$495 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$363 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$284 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.33B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...